ConductScience.org, home

Paper28126304

Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.

Doll CM and 18 others. Int J Radiat Oncol Biol Phys, 2017. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811. Papers, record 28126304. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28126304

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811.
PubMed
Journal
Int J Radiat Oncol Biol Phys
PubMed
Year
2017
PubMed
Publication types
Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2024-06-10
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Doll CMCorinne M
2Moughan JJennifer
3Klimowicz AAlexander
4Ho CKClement K
5Kornaga ENElizabeth N
6Lees-Miller SPSusan P
7Ajani JAJaffer A
8Crane CHChristopher H
9Kachnic LALisa A
10Okawara GSGordon S
11Berk LBLawrence B
12Roof KSKevin S
13Becker MJMark J
14Grisell DLDavid L
15Ellis RJRobert J
16Sperduto PWPaul W
17Marsa GWGerald W
18Guha CChandan
19Magliocco AMAnthony M

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Anus NeoplasmsMajor topic
ChemoradiotherapyMajor topic
ErbB ReceptorsMajor topic
Ki-67 AntigenMajor topic
Neoplasm ProteinsMajor topic
Adult
Aged
Aged, 80 and over
Cisplatin
Female
Fluorouracil
Humans
Male
Middle Aged
Mitomycin
Prognosis
Sex Factors
Treatment Failure
Treatment Outcome

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U10 CA180868NCI NIH HHSUnited StatesU10CA180868PubMed and NIHNIH RePORTER
UG1 CA189867NCI NIH HHSUnited StatesUG1CA189867PubMed and NIHNIH RePORTER
U10 CA037422NCI NIH HHSUnited StatesU10CA037422PubMedNIH RePORTER
U10 CA021661NCI NIH HHSUnited StatesU10CA021661PubMedNIH RePORTER
U10 CA180822NCI NIH HHSUnited StatesU10CA180822PubMed and NIHNIH RePORTER
U24 CA114734NCI NIH HHSUnited StatesU24CA114734PubMedNIH RePORTER
U24 CA180803NCI NIH HHSUnited StatesU24CA180803PubMedNIH RePORTER

Download CSV of grants

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117000658The epidermal growth factor receptor pathway: a model for targeted therapy.Clin Cancer Res2006https://conductscience.org/library/papers/17000658PubMed
215578079Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death.Mod Pathol2005https://conductscience.org/library/papers/15578079PubMed
38874455
Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
Lancet1996https://conductscience.org/library/papers/8874455PubMed
410888772Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.Arch Pathol Lab Med2000https://conductscience.org/library/papers/10888772PubMed
524662454Relationship between EGFR expression, EGFR mutation status, and the efficacy of chemotherapy plus cetuximab in FLEX study patients with advanced non-small-cell lung cancer.J Thorac Oncol2014https://conductscience.org/library/papers/24662454PubMed
618430910Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.JAMA2008https://conductscience.org/library/papers/18430910PubMed
724127500The increasing incidence of anal cancer: can it be explained by trends in risk groups?Neth J Med2013https://conductscience.org/library/papers/24127500PubMed
827052656Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.Ann Oncol2016https://conductscience.org/library/papers/27052656PubMed
924035327Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial.Int J Radiat Oncol Biol Phys2013https://conductscience.org/library/papers/24035327PubMed
1024642661KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).PLoS One2014https://conductscience.org/library/papers/24642661PubMed
1124595598EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.J Cancer Res Clin Oncol2014https://conductscience.org/library/papers/24595598PubMed
1225042878EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324.Radiother Oncol2014https://conductscience.org/library/papers/25042878PubMed
1320152769Ki67 in breast cancer: prognostic and predictive potential.Lancet Oncol2010https://conductscience.org/library/papers/20152769PubMed
1423150707
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.
J Clin Oncol2012https://conductscience.org/library/papers/23150707PubMed
1524021343p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy.Radiother Oncol2013https://conductscience.org/library/papers/24021343PubMed
1612389040Automated subcellular localization and quantification of protein expression in tissue microarrays.Nat Med2002https://conductscience.org/library/papers/12389040PubMed
1719923868Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status.Oncology2009https://conductscience.org/library/papers/19923868PubMed
1822949905Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer.Case Rep Oncol2012https://conductscience.org/library/papers/22949905PubMed
1923755922Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.Int J Radiat Oncol Biol Phys2013https://conductscience.org/library/papers/23755922PubMed
201683905A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction.J Pathol1991https://conductscience.org/library/papers/1683905PubMed

See all 37 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
40360682Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer.Nat Rev Clin Oncol2025https://conductscience.org/library/papers/40360682PubMed
36009576Biomarkers in Anal Cancer: Current Status in Diagnosis, Disease Progression and Therapeutic Strategies.Biomedicines2022https://conductscience.org/library/papers/36009576PubMed
33801992Evolution of the Role of Radiotherapy for Anal Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/33801992PubMed
32864041Prognostic role of ultrasonography staging in patients with anal cancer.World J Gastrointest Oncol2020https://conductscience.org/library/papers/32864041PubMed
31288054Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer.Int J Radiat Oncol Biol Phys2019https://conductscience.org/library/papers/31288054PubMed
29931433Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma.Mol Imaging Biol2019https://conductscience.org/library/papers/29931433PubMed
29719621Histogram analysis of ADC in rectal cancer: associations with different histopathological findings including expression of EGFR, Hif1-alpha, VEGF, p53, PD1, and KI 67. A preliminary study.Oncotarget2018https://conductscience.org/library/papers/29719621PubMed
28409247[Cetuximab plus chemoradiotherapy for anal carcinoma in immunocompetent patients does not change existing therapy standards : Results from the prospective, multicenter E3205 trial].Strahlenther Onkol2017https://conductscience.org/library/papers/28409247PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADA251816PubTator's text mininghttps://conductscience.org/library/genes/51816NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
KRAS3845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
PTEN5728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28126304

GET https://conductscience.org/api/papers/v1/28126304/references?page=2